Does the sphingosine 1-phosphate receptor-1 provide a better or worse prognostic outcome for breast cancer patients?
Pyne, Nigel J. and Pyne, Susan (2018) Does the sphingosine 1-phosphate receptor-1 provide a better or worse prognostic outcome for breast cancer patients? Frontiers in Oncology, 8 (417). pp. 1-3. ISSN 2234-943X
|
Text (Pyne-Pyne-FiO2018-Does-the-sphingosine-1-phosphate-receptor-1-provide-a-better)
Pyne_Pyne_FiO2018_Does_the_sphingosine_1_phosphate_receptor_1_provide_a_better.pdf Final Published Version License: ![]() Download (101kB)| Preview |
Official URL: https://doi.org/10.3389/fonc.2018.00417
Abstract
Recently, Lei et al., (2018) published an article in Cancer Medicine claiming a survival benefit of sphingosine 1-phosphate (S1P) and sphingosine 1-phosphate receptor 1 (S1P1) expression in breast cancer patients. This controversial study opposes the prevailing view concerning the deleterious role of S1P in cancer. This is discussed in depth in the current opinion article.
Creators(s): |
Pyne, Nigel J. ![]() ![]() | Item type: | Article |
---|---|
ID code: | 65555 |
Keywords: | sphingosine 1-phosphate, Sphingosine 1-phosphate receptor 1, breast cancer, migration, growth, Neoplasms. Tumors. Oncology (including Cancer), Oncology |
Subjects: | Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer) |
Department: | Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences |
Depositing user: | Pure Administrator |
Date deposited: | 27 Sep 2018 13:18 |
Last modified: | 21 Jan 2021 10:26 |
Related URLs: | |
URI: | https://strathprints.strath.ac.uk/id/eprint/65555 |
Export data: |
CORE (COnnecting REpositories)